Free shipping on all orders over $ 500

 About 1 result found for searched term "2227102-46-5" (0.128 seconds)

Cat.No.  Name Target
M25010 Patritumab deruxtecan Drug-Linker Conjugates for ADC
HER3-DXd; U3-1287; U3-1402
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.